[go: up one dir, main page]

MX9307644A - Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo. - Google Patents

Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo.

Info

Publication number
MX9307644A
MX9307644A MX9307644A MX9307644A MX9307644A MX 9307644 A MX9307644 A MX 9307644A MX 9307644 A MX9307644 A MX 9307644A MX 9307644 A MX9307644 A MX 9307644A MX 9307644 A MX9307644 A MX 9307644A
Authority
MX
Mexico
Prior art keywords
amino
tetrahidrobenzotiazole
propil
medication including
antidepressive effect
Prior art date
Application number
MX9307644A
Other languages
English (en)
Inventor
Franco Borsini
Rudolf Hammer
Joachim Mierau
Erich Lehr
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of MX9307644A publication Critical patent/MX9307644A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

El invento se refiere a la utilización de pramipexol y como medicamento con efecto antidepresivo que lo contiene.
MX9307644A 1992-12-05 1993-12-03 Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo. MX9307644A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4241013A DE4241013A1 (de) 1992-12-05 1992-12-05 Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung

Publications (1)

Publication Number Publication Date
MX9307644A true MX9307644A (es) 1994-06-30

Family

ID=6474503

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9307644A MX9307644A (es) 1992-12-05 1993-12-03 Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo.

Country Status (28)

Country Link
US (1) US6191153B1 (es)
EP (1) EP0675717B1 (es)
JP (1) JP3221880B2 (es)
KR (1) KR100311165B1 (es)
CN (1) CN1052400C (es)
AT (1) ATE183091T1 (es)
AU (1) AU674378B2 (es)
BG (1) BG62475B1 (es)
CA (1) CA2150131C (es)
CZ (1) CZ282679B6 (es)
DE (2) DE4241013A1 (es)
DK (1) DK0675717T3 (es)
ES (1) ES2136725T3 (es)
FI (1) FI952734A0 (es)
GR (1) GR3031521T3 (es)
HU (1) HU221014B1 (es)
IL (1) IL107870A (es)
MX (1) MX9307644A (es)
NO (1) NO306930B1 (es)
NZ (1) NZ258876A (es)
PL (1) PL309282A1 (es)
RU (1) RU2157685C2 (es)
SG (1) SG49228A1 (es)
SK (1) SK281441B6 (es)
TW (1) TW362973B (es)
UA (1) UA35604C2 (es)
WO (1) WO1994013287A1 (es)
ZA (1) ZA939065B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650420A (en) * 1994-12-15 1997-07-22 Pharmacia & Upjohn Company Pramipexole as a neuroprotective agent
US6156777A (en) 1994-12-15 2000-12-05 Pharmacia & Upjohn Company Use of pramipexole as a neuroprotective agent
US6001861A (en) * 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
DE19830201A1 (de) * 1998-07-07 2000-01-13 Boehringer Ingelheim Pharma Mittel mit antidepressiver Wirkung
CA2301899C (en) * 1998-07-27 2008-11-18 Boehringer Ingelheim Pharma Kg Agent with an antidepressant activity
PE20011074A1 (es) 2000-02-23 2001-10-04 Upjohn Co Uso de pramipexol en el tratamiento de trastornos de adiccion
WO2002004409A2 (en) * 2000-07-06 2002-01-17 Us Gov Health & Human Serv Tetrahydrobenzothiazole analogues as neuroprotective agents
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
EP1260221A3 (en) * 2001-05-23 2002-12-18 Pfizer Products Inc. Combination treatment for depression and anxiety
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
US6727247B2 (en) * 2001-12-10 2004-04-27 Hoffman-La Roche Inc. Substituted benzothiazole amide derivatives
MY142204A (en) * 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
GB2394951A (en) * 2002-11-04 2004-05-12 Cipla Ltd One pot synthesis of 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole
DE102004006808A1 (de) 2004-02-11 2005-09-01 Grünenthal GmbH Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen
RS52057B2 (sr) * 2004-08-13 2018-03-30 Boehringer Ingelheim Int Formulacija tablete sa produženim oslobađanjem koja sadrži pramipeksol ili njegovu farmaceutski prihvatljivu so
KR20070050081A (ko) * 2004-08-13 2007-05-14 베링거 인겔하임 인터내셔날 게엠베하 프라미펙솔 또는 약제학적으로 허용되는 이의 염을포함하는 연장 방출형 펠렛 제형, 이의 제조방법 및 이의용도
KR20070118103A (ko) * 2005-04-04 2007-12-13 다케다 야쿠힌 고교 가부시키가이샤 우울증 또는 불안신경증의 예방 또는 치료제
CA2626249A1 (en) * 2005-10-18 2007-04-26 Boehringer Ingelheim International Gmbh Use of pramipexol for treating moderate to severe restless legs syndrome (rls)
US20090041844A1 (en) * 2006-02-10 2009-02-12 Boehringer Ingelheim International Gmbh Modified Release Formulation
WO2007090883A1 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Extended release formulation
IL312486B2 (en) * 2017-04-10 2025-05-01 Chase Therapeutics Corp NK1 antagonist combination and method for treating synucleinopathies
KR20200026920A (ko) 2017-06-30 2020-03-11 체이스 테라퓨틱스 코포레이션 우울증을 치료하기 위한 nk-1 길항제 조성물 및 우울증 치료에 사용하는 방법
TWI672472B (zh) * 2018-08-15 2019-09-21 鄭映芳 飲料製冰機裝置
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186087B1 (de) * 1984-12-22 1989-08-23 Dr. Karl Thomae GmbH Tetrahydro-benzthiazole, deren Herstellung und deren Verwendung als Zwischenprodukte oder als Arnzneimittel
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3930282A1 (de) * 1989-09-11 1991-03-21 Boehringer Ingelheim Kg Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit

Also Published As

Publication number Publication date
NZ258876A (en) 1997-07-27
BG99700A (bg) 1996-04-30
CN1052400C (zh) 2000-05-17
NO306930B1 (no) 2000-01-17
CZ144095A3 (en) 1996-03-13
KR950703953A (ko) 1995-11-17
AU674378B2 (en) 1996-12-19
WO1994013287A1 (de) 1994-06-23
HU9501623D0 (en) 1995-08-28
ATE183091T1 (de) 1999-08-15
CA2150131A1 (en) 1994-06-23
TW362973B (en) 1999-07-01
FI952734A7 (fi) 1995-06-05
CA2150131C (en) 2004-09-21
ES2136725T3 (es) 1999-12-01
PL309282A1 (en) 1995-10-02
HK1019003A1 (en) 2000-01-14
ZA939065B (en) 1994-08-04
SK74095A3 (en) 1996-05-08
NO952207D0 (no) 1995-06-02
KR100311165B1 (ko) 2001-12-28
FI952734L (fi) 1995-06-05
EP0675717A1 (de) 1995-10-11
FI952734A0 (fi) 1995-06-05
IL107870A (en) 1996-12-05
JPH08504201A (ja) 1996-05-07
GR3031521T3 (en) 2000-01-31
HU221014B1 (hu) 2002-07-29
UA35604C2 (uk) 2001-04-16
SK281441B6 (sk) 2001-03-12
DE4241013A1 (de) 1994-06-09
HUT71798A (en) 1996-02-28
IL107870A0 (en) 1994-04-12
NO952207L (no) 1995-06-02
BG62475B1 (bg) 1999-12-30
CN1091635A (zh) 1994-09-07
DK0675717T3 (da) 2000-02-28
DE59309733D1 (de) 1999-09-16
SG49228A1 (en) 1998-05-18
RU2157685C2 (ru) 2000-10-20
CZ282679B6 (cs) 1997-08-13
EP0675717B1 (de) 1999-08-11
US6191153B1 (en) 2001-02-20
JP3221880B2 (ja) 2001-10-22
AU5715294A (en) 1994-07-04

Similar Documents

Publication Publication Date Title
MX9307644A (es) Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo.
SV1995000042A (es) Heteroaril-oxazolidinonas de 5 eslabones ref. le a 30523-sv
SV1995000045A (es) Benzoxazolil- y benzotiazoliloxazolidinonas, ref. le a 30616-sv
ES2114620T3 (es) Composiciones antitumorales que contienen derivados del taxano.
SV1995000041A (es) Heteroarik-oxazolidinonas de 6 eslabones con contenido de nitrogeno le a 30522-sv
ES2164182T3 (es) Benzociclopentanoxazolidinonas que contienen heteroatomos con actividad antibacteriana.
ES2042520T3 (es) Composiciones farmaceuticas que contienen el ester metilico de levodopa, preparacion y aplicaciones terapeuticas del mismo.
NO933947D0 (no) Baerer for en hjerteklaffprotese
ES2153836T3 (es) Composicion enmascaradora del sabor de agentes farmaceuticos amargos.
MX9300550A (es) Estructura de fibra absorbente.
ES2061688T3 (es) Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
ES2133412T3 (es) 2',5'-oligoadenilato-2',3'-ciclofosfatos y 2',5'-oligoadenilatos con actividad sobre el virus papiloma.
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
ES2158496T3 (es) Mezclas aislables a partir de granos de eugenia jambolana lamarck, su preparacion y la utilizacion de estas mezclas y de algunos de sus constituyentes como medicamentos.
ES2051695T3 (es) Tratamiento de la trombosis que contiene un fibrinolitico y un analogo de carbaciclina.
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
AR023511A1 (es) Composicion que comprende (s) y (r) 5-amino-3-ciano-1-(2,6-dicloro-4-trifluorometilfenil)-4-trifluoro-metilsulfinilpirazol, dichos compuestos aislados y usos de los mismos como plaguicida
ES2098388T3 (es) Activador de biocida.
HUP9900504A2 (en) Use of insect pheromones for producing pharmaceutical compositions having antiglucocorticoid effect
ES2038642T3 (es) Tratamiento dermico de enfermedades vermiculares del gato con pracicuantel.
ES2053629T3 (es) Resinas de bismaleinimida.
ES2033181B1 (es) Una tableta o capsula de herbicida para su aplicacion en arrozales.
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
CL2004000486A1 (es) Compuestos de (piridinil amino)-bencisoxazol y bencisotiazol substituidos, la composicion farmaceutica que los contiene, su procedimiento de preparacion a partir de un bencisoxazol o bencisotiazol y su uso como farmaco con actividad antidepresiva.
ES2104163T3 (es) Liponucleotidos de seco-nucleosidos, su preparacion al igual que su utilizacion como medicamentos antiviricos.